Top Undervalued Biotechnology industry Stocks 2026

Novavax, (NVAX) has the largest fair value gap in the Biotechnology industry at 710.1% below the modeled estimate, followed by Maravai LifeSciences Holdings, (MRVI) at 472.1%, Zai Lab (ZLAB) at 404.1%, and Moderna, (MRNA) at 284.7%.

Updated todayBased on intrinsic value modelsIndustry: Biotechnology

Page snapshot: 8 Oct 2026, 7:39 am

View full analysis in the screener → · All undervalued →

Before you trade on valuation alone

Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.

Compare price vs fair value See intrinsic value →

Biotechnology Industry Valuation Insights (Updated Today)

The Biotechnology industry currently shows an average fair value gap of 118.5% on this snapshot.
Top name Novavax, Inc. (NVAX) trades at roughly a 710.1% gap versus modeled intrinsic value—rankings move with prices and inputs.
This industry's average fair value gap is below our broad benchmark (~555.1%).

Undervalued Biotechnology Stocks by Market Cap

Large cap (top 5)

1.Moderna, Inc. · MRNA284.7%$74.38B
2.BioNTech SE · BNTX149.5%$24.05B
3.CSL Limited · CSL.AX56.5%A$87.16B
4.Genmab A/S · GMAB54.0%$23.21B
5.BioMarin Pharmaceutical Inc. · BMRN52.2%$10.87B

Mid cap (top 5)

1.Maravai LifeSciences Holdings, Inc. · MRVI472.1%$2.17B
2.Zai Lab Limited · ZLAB404.1%$2.89B
3.Apellis Pharmaceuticals, Inc. · APLS165.7%$5.25B
4.Soleno Therapeutics, Inc. · SLNO53.7%$2.76B
5.CRISPR Therapeutics AG · CRSP49.0%$5.21B

Small cap (top 5)

1.Novavax, Inc. · NVAX710.1%$1.86B
2.Intellia Therapeutics, Inc. · NTLA198.0%$1.73B
3.Ocular Therapeutix, Inc. · OCUL154.1%$1.61B
4.Nektar Therapeutics · NKTR103.2%$1.14B
5.Syndax Pharmaceuticals, Inc. · SNDX66.3%$1.54B

What Are Undervalued Biotechnology Stocks?

Undervalued biotechnology stocks are names where price sits below modeled fair (intrinsic) value—shown as a fair value gap versus the current quote.

This is not a buy list. Validate each symbol on its company page before you act.

How We Identify Undervalued Biotechnology Stocks

We pull an industry-filtered undervalued snapshot (price, fair value gap, cap, sector, country) and rank by that gap. You can sort and search in the table above.

Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.

FAQs

Answers about undervalued biotechnology names, intrinsic value, and how often this list refreshes.

What are undervalued biotechnology stocks?

They are Biotechnology names trading below modeled intrinsic value—shown here as a fair value gap versus price. Models vary; use this as a screen, not advice.

How do you find undervalued biotechnology stocks?

We load undervalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.

Why are biotechnology stocks undervalued?

Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.

Is this biotechnology list a recommendation to buy or sell?

No. Rankings are by calculated gap versus a model. Discounts can reflect risk or data lag. Check fundamentals; seek licensed advice for personal decisions.

How often is this list updated?

The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.